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The  M  variant  of encephalomyocarditis  (EMC) 1 virus  produces  a  diabetes-like 
syndrome in mice by infecting and destroying pancreatic beta cells (1-3). The severity 
of the diabetes correlates with  the degree of virus-induced  beta cell damage  (4,  5). 
Only certain inbred strains of mice develop diabetes, and susceptibility to EMC virus- 
induced  diabetes  is inherited  as  an  autosomal  recessive trait  (2,  6-8).  The  genetic 
factors controlling susceptibility operate at the level of the beta cell, and whether a 
particular strain of mouse develops diabetes appears to be related to differences in the 
permissiveness of beta cells to infection with EMC virus (9,  10). 
Previous  experiments  (5)  showed  that  when  mice  were  inoculated  with  a  high 
concentration of mouse-passaged EMC virus (10  8 plaque-forming units [PFU]), fewer 
animals developed diabetes  than  when  inoculated  with  a  low concentration  of the 
same virus (10  ~ PFU). Moreover, the diabetogenic capacity of the virus was markedly 
diminished after passage in mouse fibroblast cultures, but was restored when passaged 
in mice. This raised the possibility that the stock pool of EMC virus was made up of 
two populations of virus: one that had a tropism for beta cells and produced diabetes 
and the other that did not have a tropism for beta cells and was nondiabetogenic (5). 
The present investigation was initiated to see, first, whether our stock pool of the M 
variant of EMC virus was made up of a mixture of diabetogenic and nondiabetogenic 
virus and, second, whether the nondiabetogenic  virus inhibited  the development of 
diabetes. 
Materials and Methods 
Mice.  Unless otherwise indicated, SJL/J male mice, 5-6 wk old, obtained from The Jackson 
Laboratory, Bar Harbor, Maine, were used in all experiments. Animals were inoculated with 
virus by the intraperitoneal route. 
Pancreatic Beta Cell Cultures.  Pancreata were aseptically removed from suckling SJL/J mice, 
and beta cell cultures were prepared as described previously (9). The cultures were refed at 2- 
d intervals, and at 6 d the monolayers were used to passage virus. Staining of the monolayers 
with fluorescein  isothiocyanate-labeled antibody to insulin  indicated that 40-70% of the cells 
were beta cells (9). 
Virus.  The M variant of EMC virus (1), prepared as described elsewhere, was passaged five 
J Abbrev.iations  used in  this paper:  EMC,  encephalomyocarditis;  FITC,  fluorescein isothiocyanate;  IRI, 
immunoreactive insulin;  PFU,  plaque-forming units; SME,  secondary  mouse embryo;  VSV,  vesicular 
stomatitis virus. 
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times in beta cell cultures (9). The virus then was passaged five additional times in SJL/J male 
mice and  harvested from  hearts.  Virus titer was determined by plaque assay on  secondary 
mouse embryo (SME) cells (9). 
Plaque Purification.  The M  variant of EMC virus, prepared as described above, was diluted 
to a concentration of 1 PFU/ml, and 0.1-ml aliquots were allowed to adsorb to monolayers of 
SME cells grown in  16-well cluster dishers (9-mm-diameter wells). After adsorption for 1 h at 
37°C, cultures were overlaid with  1.5% (wt/vol) methylcellulose in Eagle's minimal essential 
medium that contained 5% fetal bovine serum.  Monolayers were stained 2 d  later with a  1: 
20,000 dilution of neutral red. When examined 24 h later, 7 of the 240 wells contained a single 
clone. The medium and the remaining cell monolayers were removed from these seven wells, 
diluted with fresh medium, and aliquots were inoculated onto confluent monolayers of SME 
cells. 2 d later, the monolayers showed extensive cytopathology, and the medium and cells were 
harvested. Six of the seven clones were tested for their ability to produce diabetes in mice and 
two of these clones, one diabetogenic and the other nondiabetogenic, were plaque-purified two 
additional  times.  In  brief,  material  from  the  original clones was  diluted,  inoculated onto 
confluent monolayers of SME cells, overlaid with methylcellulose medium, and stained with 
neutral red. Monolayers showing a single distinct circular plaque were selected, and plaques 
from these plates were harvested with a  micropipette. This material was diluted in medium, 
passaged in SME cells, and tested in mice. The plaque purification procedure was repeated a 
third time. 
Glucose and Insulin Assays.  Glucose levels (plasma) were measured, and glucose-tolerance tests 
were performed as described previously (7). Nonfasting glucose levels were measured 7 and  14 
d after infection, and single-point 60-min glucose-tolerance tests were performed 10 and  17 d 
after infection. The data obtained on these 4 d were used to calculate the glucose index (7) for 
each mouse. The mean glucose index of 110 uninfected mice was 145:1= 19 mg/dl. Any mouse 
with a  glucose index >240  mg/dl  (5  SD above the mean)  was scored as diabetic. In some 
experiments, only nonfasting glucose levels were determined. The mean nonfasting glucose of 
69 uninfected mice was  143 :t= 21  mg/dl. In these experiments, any mouse with a nonfasting 
glucose >248  mg/dl  (5  SD above the  mean)  was scored as diabetic. The  concentration  of 
immunoreactive insulin (IRI) in the pancreas and plasma of infected and uninfected mice was 
measured by radioimmunoassay (11, 12). 
Fluorescein Isothiocyanate (FITC)-labeled  Anti-EMC  Virus Antibody.  Mice  were  immunized 
intraperitoneally every week with increasing doses of EMC virus beginning with 2.0 X  10  5 PFU 
and ending with 2.0 X  10  6 PFU. Serum obtained after five or more injections was precipitated 
by ammonium sulfate, passed through a DEAE cellulose column, and the IgG fraction collected 
and  labeled with  FITC  (4,  13).  Tissue  sections  were  prepared,  stained  and  examined  as 
described previously (5). Sections from uninfected animals served as controls, and the specificity 
of the labeled immunoglobulin was established by inhibition tests with unlabeled anti-EMC 
virus serum. 
Interferon Assay.  Interferon in the supernatant fluids of cell cultures or sera from mice was 
assayed as described previously (14).  In brief, monolayers of L-929 cells in microplates were 
incubated for 5 h at 37°121 with serial twofold dilutions of samples in a 0.1-ml vol. The cells then 
were challenged with 30-40 PFU of vesicular stomatitis virus (VSV). At the end of 1 h, the 
virus  inoculum  was  removed,  the  cells  were  washed  three  times,  and  refed  with  media 
supplemented with 0.7% methylcellulose. Plaques were counted 48 h later. The interferon titer 
was expressed as the reciprocal of the highest dilution that reduced VSV plaques by 50%. 
Results 
Selection of Variants.  To see whether the original virus pool contained a  mixture of 
diabetogenic and  nondiabetogenic  virus,  individual plaques  were  selected,  cloned, 
and  inoculated  into  mice. The  data in Table I  show  that  two clones  (82  and  108) 
produced diabetes, two  (5 and  16)  produced only minimal changes in  glucose, and 
two (125 and  162)  gave intermediate results. Clones  108 and  16 were plaque-purified 
two more times and clones  108-D2  (designated D  variant)  and  16-B1  (designated B 
variant) were studied in greater depth. These latter viruses have now been passaged 880  VIRUS-INDUCED DIABETES MELLITUS 
TABLE  I 
Isolation of Diabetogenic and Nondiabetogenic Varzants 
Glucose index*  Virus  Diabetes  (Mean ±  SD) 
% 
EMC-M  252 +  136  47 
Clones:[: 
5  191 ±  44  15 
82  447 ±  75  95 
125  213 ± 89  45 
162  209 ±  43  30 
16  174 ±  45  10 
A  170 4" 64  15 
il  159 ±  57  5 
163 ±  59  25 
166 ±  53  15 
176 ±  68  20 
F  ,~  170 ±  60  10 
B-1  164 ±  12  0 
B-2  170 ±  12  0 
B-3  166 ±  15  0 
108  441 ±  49  100 
A  349 ±  135  75 
B  390 ±  145  77 
C  332 ±  121  70 
i1  430 +  126  100 
292 ±  12O  55 
414 ±  126  90 
198 ±  75  21 
H  ,,1,  164 zl: 52  10 
D-I  372 ±  61  100 
D-2  430 ±  51  100 
D-3  368 ±  65  95 
Uninfected  145 ±  19  0 
* The mean glucose index of 110 uninfected SJL/J male mice was  145 _  19 
mg/dl. Any mouse with a glucose index >240 mg/dl, which was 5 SD above 
the mean, was scored as diabetic. 
Each clone was inoculated into ~20 mice. 
at least eight  times in SME  cells and have retained their diabetogenic and nondiabe- 
togenic properties. 
Metabolic  Alterations.  Fig.  1  shows  that  when  mice  were  inoculated  with  the  D 
variant  of EMC  virus,  the  mean  glucose  level reached  500  mg/dl  within  4  d  after 
infection and remained elevated for the duration  of the experiment.  In contrast,  mice 
inoculated with the B  variant showed no elevation of blood glucose as compared  with 
unitffected controls.  As seen in Fig~ 2  A, the concentration  of IRI  in the pancreata  of 
mice  infected  with  the D  variant  was  inversely  related to  the  glucose  level. At  3  d 
after infection; pancreatic IRI was approximately one-tenth that of uninfected animals 
or  animals  infected  with  the  B  variant.  Plasma  IRI  of mice  infected  with  the  D 
variant showed an initial increase at 2 d  after infection (Fig. 2 B), presumably a  result 
of the release'of insulin  from virus-infected beta cells. This was followed by a  marked YOON,  McCLINTOCK,  ONODERA,  AND  NOTKINS  881 
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Fro.  I.  Blood glucose levels of mice infected with the D or B variant of EMC virus. Each mouse 
received 106 PFU of virus. At the times indicated, the mice were bled, and nonfasting glucose (NFG) 
levels were determined. Each point represents the mean of 10 animals; vertical bars are the SEM. 
D  variant (O), B variant (O), and uninfected controls (ll). 
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Fro.  2.  IRI in the pancreas (A) and plasma (B) of the mice infected with lO  s PFU of the D or B 
variant of EMC virus. Each point represents the mean of 10 mice; vertical  bars are the SEM.  D 
variant (O), B variant (O), and uninfected controls (B). 882  VIRUS-INDUCED DIABETES MELLITUS 
decrease  in  IRI to approximately one-third  that  of uninfected  animals or animals 
infected with the B variant. The IRI in the pancreas and plasma remained depressed 
throughout the experiment. 
Histopathologic Changes.  To see whether the differences in glucose and insulin levels 
were related to the degree of virus-induced histopathology, sections of pancreata were 
prepared at different times after infection and examined microscopically. In general, 
islets from mice infected with the B  variant showed little pathologic change  (Fig.  3 
A).  In  contrast,  islets  from  mice  infected  with  the  D  variant  showed  extensive 
destruction of beta cells (Fig. 3 B). Approximately 60% of the islets from mice infected 
with the D variant showed lymphocytic infiltration and moderate to severe destruction 
of the  islets  of Langerhans.  Another  20%  of the  islets  showed  mild  alterations.  In 
contrast,  <10%  of the  islets  from  mice  infected  with  the  B  variant  showed  mild 
inflammatory changes. 
Viral Replication.  Evidence that the destruction of the islets by the D  variant but 
not  by the  B  variant  was a  result  of differences in  the capacity of these  viruses  to 
infect and replicate in beta cells, was obtained by immunofluorescence (Figs.  3 and 
4).  When  beta  cells  from  mice  infected  with  the  D  variant  were  stained  with 
fluorescein-labeled antibody to EMC virus, ~60% of cells in the islets contained viral 
antigens, as compared with <5% of the cells in islets from animals infected with the 
B  variant.  Moreover,  by measuring  infectious  virus,  10-100  times  more  virus was 
recovered from islets  of mice infected with  the  D  variant  as compared with  the  B 
variant (Fig. 5 A). Similar differences were found in the hearts of infected mice (Fig. 
5 B). 
Immunologic Response.  To see whether the differences in viral replication might be 
related to the time of appearance or titer of neutralizing antibody, mice were infected 
with the B or D  variants, and antibody titers were determined at different times after 
infection.  Fig. 6 shows that neutralizing antibody could be detected within 4 d  after 
infection, but there was no difference in the time of appearance or titer of antibody 
when the responses to i'he B and D  variants were compared. Moreover, the B and D 
variants  are  antigenically  quite  similar  (Table  II).  Antibody  made  against  the  D 
variant  neutralized  the  D  and  B  variants  to  about  the  same  degree.  Similarly, 
antibody made against the B variant neutralized the B and D  variants equally well. 
Inhibition by the B  Variant of the Induction of Diabetes by the D  Variant.  To see whether 
the nondiabetogenic B  variant had any effect on the induction  of diabetes by the D 
variant, the two viruses were mixed at varying ratios and inoculated into SJL/J mice. 
The data in Table III show that as little as 102 pFU of the D variant induced diabetes 
in  77%  of the mice. Between 95  and  100%  Of the animals developed diabetes when 
inoculated with >--104 PFU. In contrast, none of the animals developed diabetes when 
inoculated with up to  105 PFU of the B variaot. When, however, the B variant was 
inoculated with the D variant, at a  1:1 ratio, only 60% of the mice developed diabetes, 
as compared with 95% with D  alone.  When  the B  and D  va÷iants were mixed at a 
ratio of 9:1, <--11% of the mice developed diabetes, and none developed diabetes when 
the B and D  variants were mixed at a  ratio of 99:1. 
In other experiments, mice were first inoculated with the B variant (5 ×  105 PFU) 
and, then given the D  variant  (5×  10  5 PFU)  at~iciifferent  times thereafter. The data 
in Table IV show that none of these animals developed diabetes. 
Mechanism of Inhibition of the Induction of Diabetes.  The B variant might inhibit  the YOON,  McCLINTOCK,  ONODERA,  AND  NOTKINS  883 
Flo.  3.  Sections of pancreas from mice infected with the B or D variant of EMC virus. (A) Section 
taken  7 d  after infection with  the  B  variant showing little or  no  inflammation in  the islets  of 
Langerhans. Hematoxylin and eosin stained. ×  ,550. (B) Section taken 7 d after infection with the 
D  variant  showing extensive  inflammatory infiltrate  in  the  islets  of Langerhans and  beta cell 
necrosis.  Hematoxylin and eosin stained. × 550.  (C) Section obtained 3 d after infection with the B 
vari~/nt  and stained with FITC.labeled anti-EMC virus antibody. Only a  few  cells in  the islets 
contain  viral antigens.  × 340.  (D)  Section obtained  3 d  after infection With  the D  variant and 
stained with FITC-labeled anti-EMC virus antibody. The majority of the cells in the islets contain 
viral antigens. The surrounding acinar cells show little fluorescence. × 340. 
induction  of diabetes by the D  variant  if the immune  response to the former occurred 
more  rapidly  or  resulted  in  higher  antibody  titers,  The  data  in  Fig.  6  and  Table  II 
show  that  this  is not  the case.  Further  evidence  that  the  immune  response  to  the  B 
variant  is not responsible for inhibition  of diabetes by the D  variant  comes from cell 
culture  experiments  that  bypass  the immune  response.  SME  cells were infected'with 60 
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Fro.  4.  Percentage of cells containing viral antigens in the islets of Langerhans of mice infected 
with the B or D  variant of EMC virus. Mice were infected with 5  ×  105 PFU of virus, and at 
different  times thereafter, sections of pancreas were stained with FITC-labeled anti-EMC virus 
antibody, and the percentage of islet cells containing viral antigens was determined. At each time 
point, between 1,500 and 2,500 cells were examined, D variant (0) and B variant (O). 
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Fro.  5.  Comparison of viral replication in the islets  of Langerhans (A)  and heart  (B)  of mice 
infected with the B or D  variant of EMC virus. Mice were inoculated intraperitoneally with 10  s 
PFU  of virus.  At  the times indicated, pancreata were  removed  from  two  mice, the islets  were 
isolated, homogenized, and assayed for infectious virus on SME cells (9).  Similarly, hearts were 
removed from the same mice, homogenized, and assayed for infectious virus. The data represent the 
mean of the individual determinations. D variant (0) and B variant (O). 
the B  variant, the D  variant, or a  l:l  mixture  of the B  and  D  variants. As seen in Fig. 
7  A,  close  to  50  times  more  virus was  produced  in  cultures  infected  with  the  D  as 
compared  with the B  variant. Moreover, the mixture of the D  and B  variants produced 
considerably  less  infectious  virus  than  the  D  variant  alone.  When  the  supernatant YOON,  McCLINTOCK,  ONODERA,  AND  NOTKINS 
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F~G. 6.  Titer of neutralizing antibody in the serum of mice infected with the D  or B  variant of 
EMC virus. Mice were inoculated intraperitoneally with  106 PFU of virus. At the times indicated, 
three mice from each group were bled, the sera pooled, and antibody titers were determined. The 
data represent the mean of the two separate experiments. D variant (O) and B variant  (C)). 
TABLE  II 
Serologic Relationship of the D and B  Variants of EMC Virus 
Variants (NeutrMizing 
Antiserum*  Antibody Tit er)::]: 
D  B 
Anti-D  2,560  1,280 
Ant  i-B  5,120  2,560 
* For the preparation ofantiviral antibody, rabbits were immunized intraper  -~ 
itoneally every week with increasing doses of the D or B variants beginning 
with 5  ×  106 PFU and ending with 5 X  107 PFU. Sera were obtained after 
seven injections. 
Neutralization titers are expressed as the reciprocal of the highest dilution of 
serum that inhibited plaque formation by 50%. 
fluids  were examined  for interferon  (Fig.  7  B),  the  D  variant  induced  little  if any 
interferon  (<10),  whereas sttbstantial amounts of interferon were induced within  12 
h  by the  B  variant. The  mixed pool, which  contained  both  the B  and  D  variants, 
induced intermediate amounts of interferon. Although there was a marked difference 886  VIRUS-INDUCED DIABETES  MELLITUS 
TABLE III 
Inhibition of Vitus-lnduced Diabetes by the Nondiabetogenic B  Variant* 
Virus 
D  B 
B:D ratio  Glucose index:]:  Diabetes 
(Mean ±  SD) 
PFU/mouse 
1.0 X  106 
1.0 X  10  5 
1.0 x  lO  4 
l.OX  1o  3 
1.0 X  102 
1.0 x  lo  5 
1.0×  104 
5.0 ×  104  5.0 ×  104  1 
5.0 x  103  5.0 ×  103  l 
1.0 ×  104  9.0 ×  104  9 
1.0 x  l03  9.0 x  103  9 
1.0 ×  102  9.0 ×  102  9 
1.0 X  10  a  9.9 X  l04  99 
1.0 X  10  z  9.9 X  104  999 
Uninfected 
% 
461 ±  79  100 
439 ±  67  100 
396 :t: 79  95 
342 ±  97  80 
318 ::l: 79  77 
155 ±  16  0 
159 -4- 19  0 
312 ::l: 108  60 
242 ±  86  50 
189 +  89  11 
176 ±  29  5 
163 ±  17  0 
156 -I- 15  0 
152 ±  9  0 
152 ±  16  0 
* SJL/J mice were inoculated with the D variant alone, 
or a mixture of B and D at different ratios. 
Each group contained between 10 and 20 mice. 
the B variant alone, 
TABLE  IV 
Inoculation of D  Variant at Different Times After the B  Variant 
Glucose index:[: 
Days after B variant*  (Mean ±  SD)  Diabetes 
% 
1  146 ±  20  0 
2  164 ±  14  0 
3  153 =l= 20  0 
4  152 ±  14  0 
5  150 ±  15  0 
6  148 ±  29  0 
7  149±  11  0 
D variant alone  405 ±  84  100 
B variant alone  143 ±  35  0 
Uninfected  151 +  12  0 
* SJL/J mice were inoculated with 5  ×  105  PFU of the B  variant and at 
different times thereafter challenged with 5 ×  105 PFU of the D variant. 
:[ Each group contained 10 mice. 
in  the induction of interferon by the B  and  D  variants, both of these variants were 
equally sensitive to the antiviral action of mouse interferon when tested on SME  cells 
(data not shown). 
To  see whether  the B  and  D  variants induced different amounts  of interferon in 
vivo, mice were infected, and, at various times thereafter, sera were drawn and assayed 
for interferon. Fig. 8  shows that substantial amounts  of interferon were induced  by 
the B  variant within  10  h.  In contrast, peak interferon tilers were not reached until 
~30 h  after infection with the D  variant, and the maximum  titer was approximately YOON,  McCLINTOCK,  ONODERA,  AND  NOTKINS  887 
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FIC.  7.  Viral  replication  and interferon  titer in cultures infected with the B or D  variant  of EMC 
virus.  Confluent  monolayers  of SME cells in 60-ram  plates were inoculated  with  the D  variant  (5 
×  107 PFU), the B variant  (5 ×  107 PFU), or a  l:l  mixture of the two (2.5 ×  l07 PFU of each). The 
multiplicity  of infection  was ~  10. At the end of I h, the monolayers were washed, and at different 
times  thereafter,  supernatant  fluids  were assayed  for  infectious  virus  (A)  or  interferon  (B).  Each 
point  represents the mean of duplicate  plates.  D  variant  (O), B  variant  (O), and mixture of B  and 
D  (A). 
zoo 
18o 
18o 
14o 
¢  12o 
,,  ,  ,  ,  ,  ,  4,  "v-~ 
0  20  40  6@  m  100  120 
HOURS AFTER INFECTION 
Fro.  8.  Interferon levels in the circulation of mice infected with the B or D variant of EMC virus. 
Mice were infected with 5 ×  105 PFU of virus. At the times indicated, three mice from each group 
were bled, sera pooled, and interferon titers were determined. The data represent the mean of two 
experiments. D variant (O), B variant (O), and uninfected controls (A). 
one-third that with the B variant. These findings suggest  that induction of interferon 
by the B variant may inhibit replication of the D  variant, thereby preventing the 
development of diabetes. 
Host  Differences in  the  Development of Diabetes.  Earlier  studies  showed  that  only 888  VIRUS-INDUCED DIABETES  MELLITUS 
certain inbred strains of mice developed diabetes when infected with the M  variant 
of EMC  virus  (2,  6-8).  The demonstration  here  that  the  M  variant  represents  a 
mixture of the B and D variants raised the possibility that the D variant alone might 
have a different host spectrum. To test this possibility, different inbred strains of mice 
were infected with the D  variant, and blood glucose indexes were determined. Table 
V shows that certain strains of mice developed diabetes, whereas others did not. The 
spectrum of host  susceptibility, in  general, was  similar to that  observed previously 
with the M  variant  (6-8), except the glucose indexes and the percentage of animals 
developing diabetes were higher with the D  variant. In previous experiments, the A/ 
J  strain  of mice  showed  abnormal  glucose  tolerance  tests  but  were  not  diabetic, 
whereas in the present experiment -50% of the A/J mice developed diabetes. 
Discussion 
The experiments reported here show that our stock pool of EMC virus contains two 
variants: one diabetogenic and the other nondiabetogenic. The diabetogenic D variant 
infects  and  destroys  pancreatic  beta  cells,  thus  resulting  in  hypoinsulemia  and 
hyperglycemia, whereas the nondiabetogenic B variant causes little, if any, beta cell 
damage. 
Why the D variant, but not the B variant, infects and destroys pancreatic beta cells 
is still not known. One possibility is that differences exist in the capsid polypeptides 
of the B and  D  variants. Viral  receptors on the surface of beta cells may recognize 
these differences allowing the D  but not  the B variant to infect beta cells. Another 
possibility is that  the host responds immunologically more rapidly to the B than to 
the D  variant, thereby eliminating the infection before substantial beta cell damage 
has occurred.  However, our experiments indicate that  the time of appearance and 
magnitude of the immune response to the D and B variants are quite similar. A third 
possibility, presently under investigation, is that the higher interferon titers induced 
by the B variant in the circulation of mice actually protects beta cells from infection 
by the B variant. 
TABLE V 
Induction of Diabetes by the D  Variant in Different Inbred Strains of Mice* 
Strain:~  Glucose index 
(Mean ±  SD)  Diabetes 
% 
SWR/J  436 +  102  100 
DBA/2J  376 ::t: 96  95 
DBA/2J (~?)  177 :t: 32  25 
NIH/Swiss  259 ±  81  73 
NFS/N  230 +  78  52 
A/J  234 +  101  50 
C3H/HeJ  t7t  +  30  14 
C57BL/6J  143 +  25  0 
AKR/J  129 +  11  0 
CBA/J  148 ±  20  0 
LP/J  135 +  13  0 
CE/J  152 zt:  14  0 
* Mice were injected  with  105  PFU of the D  variant.  Each  group 
-20 mice. 
~: All mice were males, except where indicated  (9). 
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Antigenically, the B and D variants cannot be distinguished by the sensitive plaque- 
neutralization assay.  Competition radioimmunoassays also  have  failed to find any 
major differences between  these  two variants,  although  small  antigenic  differences 
have not been excluded (P. R. McClintock. Unpublished results.). Thus far, molecular 
hybridization  studies  with  a  [aH]cDNA  probe  of the  D  variant  have  failed  to 
distinguish the D and B variants (G. S. Aulakh. Personal communication.). Nonethe- 
less, these variants differ biologically not only in their capacity to produce diabetes, 
but also in the titer of virus produced and the amount of interferon induced. Current 
RNA-fingerprinting studies may prove more sensitive in identifying differences in the 
nucleotide sequences of the two variants. 
Of particular  interest  was  the  observation  that  the  nondiabetogenic  B  variant 
inhibits  the induction of diabetes by the D  variant. The most  likely explanation is 
that  the  rapid  induction  of interferon  by  the  B  variant  protects  beta  cells  from 
infection by the D  variant, especially when both viruses are inoculated at the same 
time. The B variant also inhibited the induction of diabetes if inoculated from 1 to 7 
d before the D variant (Table IV). Because, in our experiments, interferon disappeared 
from  the  circulation  within  4  d  after  inoculation  of the  B  variant  (Fig.  8),  the 
protection observed after 4 d  is most likely a  result of the presence of cross-reacting 
neutralizing antibody. Thus, interferon and antibody, acting alone or in combination, 
appear to contribute to the B variant-induced inhibition of diabetes. 
It  has  been  known  for some  time  that  only certain  inbred  strains  of mice  are 
susceptible to EMC  virus-induced diabetes  (2,  6-8). The present  study with the D 
variant  supports  this  observation.  Moreover, the  hyperglycemia caused  by  the  D 
variant  was  often  more severe than  that  observed in  earlier experiments with  our 
stock EMC virus pool, which suggests that, in those experiments, the B variant may 
have inhibited the development of diabetes. It also has been proposed that the genetic 
differences in susceptibility might  be related to the number or type of EMC  virus 
receptors on the surface of cells (15, 16). The inhibition of diabetes by interferon raises 
still another possibility: that genetic factors might control the host's interferon response 
to infection with the D variant. Ongoing experiments, however, indicate that the time 
of appearance  and  amount  of interferon produced  in  response to the  D  variant  is 
approximately  the  same  in  diabetes-resistant  C57BL/6J  mice  and  diabetes-prone 
SjL/j  mice. Interferon, nonetheless, may be important if beta cells from C57BL/6J 
mice, as  compared with  SJL/J  mice, are  more sensitive  to  the  antiviral  action  of 
interferon and are thus rendered resistant to infection and the subsequent development 
of diabetes.  Differences in  the  sensitivity of certain  cells  to  the  antiviral  action of 
interferon have been demonstrated in other systems (17,  18). 
Whether viruses play anything more than a  minor role in the etiology of insulin- 
dependent diabetes mellitus remains to be established (3, 19, 20), but the experiments 
with  D  and  B  variants  illustrate  some of the  potential  difficulties that  might  be 
encountered in attempting to isolate and identify diabetogenic viruses in the human 
population.  First,  by  neutralization  tests,  it  was  not  possible  to  distinguish  the 
diabetogenic from the nondiabetogenic variant of EMC virus. Similar problems might 
very well be encountered when searching for diabetogenic variants of common human 
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contained a mixture of diabetogenic and nondiabetogenic variants that could not be 
distinguished  antigenically or morphologically, each virus plaque had  to be tested 
individually for diabetes in animals. If the nondiabetogenic particles in the pool had 
greatly outnumbered the diabetogenic particles, the chance of isolating the diabeto- 
genie  variant  would  have  been  greatly reduced.  In  our EMC  virus  pool,  the  two 
variants  appear  to  have  been  present  in  nearly  equal  amounts;  and,  once  the 
diabetogenic variant was plaque purified, it remained stable on passage in SME cells. 
In contrast, attempts to isolate and plaque purify a diabetogenic variant from a pool 
of Coxsackie virus B4 that produces diabetes in mice (21) has thus far been unsuccessful 
(A. Toniolo and G. W. Jordan. Unpublished data.). Presumably, the nondiabetogenic 
virus is in great excess. Third, as demonstrated  in  the present  report, diabetogenic 
variants  in  virus  pools  may  not  always  be  detected  when  inoculated  in  animals 
because of interference produced by nondiabetogenic variants. Moreover, passage in 
certain tissue-culture cell lines of virus pools that contain a mixture of variants might 
favor replication of the interfering or non-beta tropic variant. This may account for 
the poor, and  sometimes changing,  diabetogenicity of some of our virus  pools  (5). 
Lastly, the studies with  EMC  virus have shown  that  only certain inbred strains  of 
mice  will  develop diabetes  and  that  susceptibility is  genetically controlled  (6-10). 
Although the strains of mice that are diabetes prone or diabetes resistant are known 
for EMC virus, other strains of mice or species may be required to demonstrate the 
potential diabetogenicity of human isolates. 
Summary 
Plaque purification of the M  variant of encephalomyocarditis (EMC) virus resulted 
in  the isolation of two stable variants:  one diabetogenic and  designated D  and  the 
other nondiabetogenic and  designated B. When the D  variant was  inoculated into 
SJL/J  male  mice, hypoinsulinemia and  hyperglycemia developed in  >90%  of the 
animals.  In  contrast,  none  of the  mice  inoculated  with  the  B  variant  developed 
diabetes. Histologic examination of pancreata from mice infected with the D variant 
revealed insulitis and necrosis of beta cells, whereas islets from mice infected with the 
B variant showed little, if any, change. When islets were assayed for infectious virus, 
10 times more virus was recovered from animals inoculated with the D as compared 
with  the  B  variant.  Moreover,  -60%  of islet  cells  from  mice  infected with  the  D 
variant  contained  viral  antigens  when  stained  with  fluorescein-labeled  anti-EMC 
virus antibody, whereas <5% of islet cells from animals infected with the B variant 
contained viral antigens. 
Co-infection experiments showed that the induction of diabetes by the D  variant 
was inhibited by the B variant. When the B and D  variants were mixed together at 
B:D  ratios  of  1,  9,  and  99,  diabetes  developed  in  60,  11,  and  0%  of the  mice, 
respectively. Tissue-culture experiments revealed that the B variant induced consid- 
erably  more  interferon  than  the  D  variant,  and  studies  in  animals  showed  that 
interferon appeared earlier and in greater amounts in the circulation of mice infected 
with the B as compared with the D  variant. These studies suggest that the induction 
of interferon by the  B  variant  is,  at  least  in  part,  responsible for the  inhibition  of 
diabetes by the D  variant. YOON,  McCLINTOCK, ONODERA,  AND NOTKINS  891 
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